Medicamenteuze behandeling covid-19 in de tweede lijn

Marjolein P M Hensgens; Emilie Gieling; Dylan de Lange; Wim G Boersma; Paul van der Linden; Bhanu N M Sinha; Mark de Boer

Medicamenteuze behandeling covid-19 in de tweede lijn

Translated title of the contribution: Current inpatient treatment options for COVID-19: an update

Marjolein P M Hensgens, Emilie Gieling, Dylan de Lange, Wim G Boersma, Paul van der Linden, Bhanu N M Sinha, Mark de Boer

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

In this article we provide an overview of the current treatment recommendations for COVID-19. These recommendations are made by the SWAB (StichtingWerkgroepAntibioticabeleid), in cooperation with the FMS (FederatieMedischSpecialisten (online: swab.nl/nl/covid-19.). Treatment options for patients in both ambulatory care and admitted to the hospital are listed. These treatment options include both antiinflammatory and antiviral therapy.

Translated title of the contribution	Current inpatient treatment options for COVID-19: an update
Original language	Dutch
Article number	D6857
Journal	Nederlands Tijdschrift voor Geneeskunde
Volume	166
Publication status	Published - 21 Jul 2022

Keywords

COVID-19
Hospitalization
Humans
Inpatients
SARS-CoV-2

Cite this

@article{930d26a93cea4be7a7acdfbb68b26be9,

title = "Medicamenteuze behandeling covid-19 in de tweede lijn",

abstract = "In this article we provide an overview of the current treatment recommendations for COVID-19. These recommendations are made by the SWAB (StichtingWerkgroepAntibioticabeleid), in cooperation with the FMS (FederatieMedischSpecialisten (online: swab.nl/nl/covid-19.). Treatment options for patients in both ambulatory care and admitted to the hospital are listed. These treatment options include both antiinflammatory and antiviral therapy.",

keywords = "COVID-19, Hospitalization, Humans, Inpatients, SARS-CoV-2",

author = "Hensgens, {Marjolein P M} and Emilie Gieling and {de Lange}, Dylan and Boersma, {Wim G} and {van der Linden}, Paul and Sinha, {Bhanu N M} and {de Boer}, Mark",

year = "2022",

month = jul,

day = "21",

language = "Dutch",

volume = "166",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "Bohn Stafleu van Loghum",

}

TY - JOUR

T1 - Medicamenteuze behandeling covid-19 in de tweede lijn

AU - Hensgens, Marjolein P M

AU - Gieling, Emilie

AU - de Lange, Dylan

AU - Boersma, Wim G

AU - van der Linden, Paul

AU - Sinha, Bhanu N M

AU - de Boer, Mark

PY - 2022/7/21

Y1 - 2022/7/21

N2 - In this article we provide an overview of the current treatment recommendations for COVID-19. These recommendations are made by the SWAB (StichtingWerkgroepAntibioticabeleid), in cooperation with the FMS (FederatieMedischSpecialisten (online: swab.nl/nl/covid-19.). Treatment options for patients in both ambulatory care and admitted to the hospital are listed. These treatment options include both antiinflammatory and antiviral therapy.

AB - In this article we provide an overview of the current treatment recommendations for COVID-19. These recommendations are made by the SWAB (StichtingWerkgroepAntibioticabeleid), in cooperation with the FMS (FederatieMedischSpecialisten (online: swab.nl/nl/covid-19.). Treatment options for patients in both ambulatory care and admitted to the hospital are listed. These treatment options include both antiinflammatory and antiviral therapy.

KW - COVID-19

KW - Hospitalization

KW - Humans

KW - Inpatients

KW - SARS-CoV-2

UR - http://www.scopus.com/inward/record.url?scp=85136858214&partnerID=8YFLogxK

M3 - Article

C2 - 36036698

SN - 0028-2162

VL - 166

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

M1 - D6857

ER -

Medicamenteuze behandeling covid-19 in de tweede lijn

Abstract

Keywords

Other files and links

Fingerprint

Cite this